HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Choledocholithiasis--in vivo stone dissolution using methyl tertiary butyl ether (MTBE).

Abstract
We report a series of 10 elderly patients with large bile duct calculi refractory to standard endoscopic extraction techniques who were treated by gall stone dissolution using methyl tertiary butyl ether (MTBE) instilled through a nasobiliary catheter. In eight patients complete bile duct clearance was achieved after an average of eight hours MTBE instillation. In two patients gall stone size did not change. Both underwent operative gall stone removal and subsequent stone analysis showed low cholesterol content, which is unlikely to respond to MTBE. Apart from occasional transient nausea and drowsiness, no adverse reactions were noted. Methyl tertiary butyl ether appears to be a powerful in vivo gall stone dissolution agent which, from preliminary studies, is not associated with serious toxicity.
AuthorsW R Murray, G LaFerla, G M Fullarton
JournalGut (Gut) Vol. 29 Issue 2 Pg. 143-5 (Feb 1988) ISSN: 0017-5749 [Print] England
PMID3345924 (Publication Type: Journal Article)
Chemical References
  • Ethers
  • Methyl Ethers
  • Solvents
  • methyl tert-butyl ether
Topics
  • Aged
  • Aged, 80 and over
  • Ethers (therapeutic use)
  • Female
  • Gallstones (therapy)
  • Humans
  • Male
  • Methyl Ethers
  • Solvents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: